Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT

被引：6
|
作者：
Hoglund, P [1 ]
Leander, P
Hustvedt, SO
Kloster, Y
机构：
[1] Univ Lund Hosp, Dept Clin Pharmacol, SE-22185 Lund, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Diagnost Radiol, Malmo, Sweden
[3] Nycomed Imaging AS, Oslo, Norway
来源：
ACADEMIC RADIOLOGY | 1998年 / 5卷
关键词：
D O I：
10.1016/S1076-6332(98)80056-1
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 18 条
  • [1] Safely and pharmacokinetics of a new liposomal liver-specific contrast agent for CT - Results of clinical testing in nonpatient volunteers
    Spinazzi, A
    Ceriati, S
    Pianezzola, P
    Lorusso, V
    Luzzani, F
    Fouillet, X
    Alvino, S
    Rummeny, EJ
    INVESTIGATIVE RADIOLOGY, 2000, 35 (01) : 1 - 7
  • [2] New liposomal liver-specific contrast agent for CT: First human phase I clinical trial assessing efficacy and safety
    Leander, P
    Hoglund, P
    Kloster, Y
    Borseth, A
    ACADEMIC RADIOLOGY, 1998, 5 : S6 - S8
  • [3] A new liposomal liver-specific contrast agent for CT:: first human phase-I clinical trial assessing efficacy and safety
    Leander, P
    Höglund, P
    Borseth, A
    Kloster, Y
    Berg, A
    EUROPEAN RADIOLOGY, 2001, 11 (04) : 698 - 704
  • [4] A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety
    P. Leander
    Peter Höglund
    Arve Børseth
    Yngvil Kloster
    Arne Berg
    European Radiology, 2001, 11 : 698 - 704
  • [5] Safety and pharmacokinetics of BR21, a liver-specific CT agent, in healthy volunteers
    Spinazzi, A
    Ceriati, S
    Lorusso, V
    Pianezzola, P
    Zaccarini, P
    Fouillet, X
    ACADEMIC RADIOLOGY, 1998, 5 : S20 - S22
  • [6] Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans
    SchuhmannGiampieri, G
    Mahler, M
    Roll, G
    Maibauer, R
    Schmitz, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (07): : 587 - 596
  • [7] Dysprosium EOB DTPA: A new liver-specific contrast agent for computed tomography
    Schuhmann-Giampieri, G
    Rupp, K
    Muschick, P
    Treher, M
    Werner, K
    ACADEMIC RADIOLOGY, 1998, 5 : S90 - S92
  • [8] Dysprosium EOB DTPA: A new liver-specific contrast agent for computed tomography - Discussion
    Mattrey
    Schuhmann-Giampieri
    DeHaen
    Koenig
    Hammerstingl
    Weinmann
    Kono
    Fritz
    Oksendal
    Spinazzi
    ACADEMIC RADIOLOGY, 1998, 5 : S93 - S94
  • [9] PHARMACOKINETICS IN RATS, DOGS AND MONKEYS OF A GADOLINIUM CHELATE USED AS A LIVER-SPECIFIC CONTRAST AGENT FOR MAGNETIC-RESONANCE-IMAGING
    SCHUHMANNGIAMPIERI, G
    FRENZEL, T
    SCHMITTWILLICH, H
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1993, 43-2 (08): : 927 - 931
  • [10] NONLINEAR PHARMACOKINETIC MODELING OF A GADOLINIUM CHELATE USED AS A LIVER-SPECIFIC CONTRAST AGENT FOR MAGNETIC-RESONANCE-IMAGING
    SCHUHMANNGIAMPIERI, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-2 (09): : 1020 - 1024
12